Lukas Bubendorf
#153,060
Most Influential Person Now
Researcher
Lukas Bubendorf's AcademicInfluence.com Rankings
Lukas Bubendorfcomputer-science Degrees
Computer Science
#8204
World Rank
#8626
Historical Rank
Machine Learning
#3291
World Rank
#3330
Historical Rank
Artificial Intelligence
#3594
World Rank
#3645
Historical Rank
Database
#5229
World Rank
#5429
Historical Rank
Download Badge
Computer Science
Lukas Bubendorf's Degrees
- PhD Computer Science ETH Zurich
- Masters Computer Science ETH Zurich
- Bachelors Computer Science ETH Zurich
Similar Degrees You Can Earn
Why Is Lukas Bubendorf Influential?
(Suggest an Edit or Addition)Lukas Bubendorf's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Tissue microarrays for high-throughput molecular profiling of tumor specimens (1998) (4219)
- Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. (2000) (1652)
- Gene-expression profiles in hereditary breast cancer. (2001) (1045)
- Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays. (1999) (606)
- PD‐L1 Immunohistochemistry Comparability Study in Real‐Life Clinical Samples: Results of Blueprint Phase 2 Project (2018) (525)
- Tissue microarrays for gene amplification surveys in many different tumor types. (1999) (458)
- Tissue microarray (TMA) technology: miniaturized pathology archives for high‐throughput in situ studies (2001) (396)
- High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. (1999) (393)
- Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression. (2000) (387)
- Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays. (1999) (361)
- Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers (2006) (360)
- Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade (2001) (320)
- Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer. (2001) (304)
- Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis. (2000) (297)
- Elevated expression of inhibitor of apoptosis proteins in prostate cancer. (2003) (252)
- Signal transducer and activator of transcription-5 activation and breast cancer prognosis. (2004) (233)
- Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings. (2001) (227)
- Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological subtypes. (1998) (227)
- The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group. (2012) (218)
- EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations (2012) (211)
- Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer. (2014) (209)
- Ki67 LABELLING INDEX: AN INDEPENDENT PREDICTOR OF PROGRESSION IN PROSTATE CANCER TREATED BY RADICAL PROSTATECTOMY (1996) (207)
- Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer (2004) (201)
- Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study. (2012) (197)
- Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer. (2019) (182)
- Testing for ROS1 in non-small cell lung cancer: a review with recommendations (2016) (181)
- Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays. (2002) (179)
- Prognostic significance of Bcl-2 in clinically localized prostate cancer. (1996) (174)
- Expression patterns of potential therapeutic targets in prostate cancer (2005) (171)
- Prevalence and clinical outcomes for patients with ALK-positive resected stage I to III adenocarcinoma: results from the European Thoracic Oncology Platform Lungscape Project. (2014) (168)
- PD-L1 Testing for Lung Cancer in 2019: Perspective from the IASLC Pathology Committee. (2019) (163)
- Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European Expert Group (2015) (149)
- Enhanced Expression of ANO1 in Head and Neck Squamous Cell Carcinoma Causes Cell Migration and Correlates with Poor Prognosis (2012) (145)
- Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer (2015) (140)
- Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signaling (2001) (140)
- Tissue microarray analysis reveals prognostic significance of syndecan‐1 expression in prostate cancer (2003) (137)
- Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway. (2007) (136)
- ROS signaling by NOX4 drives fibroblast-to-myofibroblast differentiation in the diseased prostatic stroma. (2011) (134)
- HER2 gene status in primary breast cancers and matched distant metastases (2007) (134)
- Stat3 promotes metastatic progression of prostate cancer. (2008) (133)
- ANX7, a candidate tumor suppressor gene for prostate cancer (2001) (133)
- IASLC MULTIDISCIPLINARY RECOMMENDATIONS FOR PATHOLOGIC ASSESSMENT OF LUNG CANCER RESECTION SPECIMENS FOLLOWING NEOADJUVANT THERAPY. (2020) (132)
- Expression of Voltage-Gated Potassium Channels in Human and Mouse Colonic Carcinoma (2007) (130)
- Activation of Signal Transducer and Activator of Transcription-5 in Prostate Cancer Predicts Early Recurrence (2005) (130)
- Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non–Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers (2018) (124)
- KCNMA1 gene amplification promotes tumor cell proliferation in human prostate cancer (2007) (124)
- ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor (2010) (121)
- Multi‐target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancer (2006) (120)
- Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer. (2001) (116)
- Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo. (2010) (116)
- Guidelines for processing and reporting of prostatic needle biopsies (2003) (113)
- Advancing a clinically relevant perspective of the clonal nature of cancer (2011) (111)
- Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells. (2008) (110)
- Ki67 labeling index in core needle biopsies independently predicts tumor-specific survival in prostate cancer. (1998) (108)
- Chromosome 8p deletions are associated with invasive tumor growth in urinary bladder cancer. (1997) (107)
- Epidermal growth factor receptor expression is associated with rapid tumor cell proliferation in renal cell carcinoma. (1997) (101)
- The prognostic value of cytology and fluorescence in situ hybridization in the follow‐up of nonmuscle‐invasive bladder cancer after intravesical Bacillus Calmette‐Guérin therapy (2009) (101)
- Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancers (2007) (100)
- Expression of Bcl-2 family member Bid in normal and malignant tissues. (2002) (98)
- The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee (2020) (97)
- Detection of ALK-Positive Non–Small-Cell Lung Cancers on Cytological Specimens: High Accuracy of Immunocytochemistry with the 5A4 Clone (2013) (91)
- Patterns of Pulmonary Complications Associated with Sirolimus (2006) (89)
- ERK1/2 and p38 MAP kinase control MMP‐2, MT1‐MMP, and TIMP action and affect cell migration: A comparison between mesothelioma and mesothelial cells (2006) (89)
- Risk factors for polyoma virus nephropathy (2008) (88)
- An international telecytologic quiz on urinary cytology reveals educational deficits and absence of a commonly used classification system. (2006) (87)
- Prognostic value of the autophagy markers LC3 and p62/SQSTM1 in early-stage non-small cell lung cancer (2016) (86)
- Discovery of new DNA amplification loci in prostate cancer by comparative genomic hybridization * (2001) (85)
- Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small‐volume or low‐grade prostate cancer (2009) (83)
- Expression of NKX3.1 in normal and malignant tissues (2003) (83)
- Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologists (2016) (82)
- Tumor mutational burden assessed by targeted NGS predicts clinical benefit from immune checkpoint inhibitors in non‐small cell lung cancer (2019) (81)
- Fluorescence in situ hybridization in the definitive diagnosis of malignant mesothelioma in effusion cytology. (2010) (81)
- Role of KCNMA1 in Breast Cancer (2012) (81)
- Urine cytology findings of polyomavirus infections. (2006) (80)
- A Grading system for invasive pulmonary adenocarcinoma: a proposal from the IASLC pathology committee. (2020) (78)
- High–Throughput Microarray Technologies: From Genomics to Clinics (2001) (76)
- Transcription factor Stat3 stimulates metastatic behavior of human prostate cancer cells in vivo, whereas Stat5b has a preferential role in the promotion of prostate cancer cell viability and tumor growth. (2010) (75)
- Basal activation of transcription factor signal transducer and activator of transcription (Stat5) in nonpregnant mouse and human breast epithelium. (2002) (75)
- Nonsmall cell lung carcinoma: diagnostic difficulties in small biopsies and cytological specimens (2017) (74)
- Guidelines on processing and reporting of prostate biopsies: the 2013 update of the pathology committee of the European Randomized Study of Screening for Prostate Cancer (ERSPC) (2013) (73)
- High expression of indoleamine 2,3-dioxygenase gene in prostate cancer. (2008) (73)
- Multicenter Immunohistochemical ALK-Testing of Non–Small-Cell Lung Cancer Shows High Concordance after Harmonization of Techniques and Interpretation Criteria (2014) (72)
- Characterization and Clinical Relevance of ALDHbright Populations in Prostate Cancer (2013) (71)
- Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer (2014) (71)
- Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer. (2014) (70)
- Screening for ALK in non-small cell lung carcinomas: 5A4 and D5F3 antibodies perform equally well, but combined use with FISH is recommended. (2015) (70)
- A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee (2020) (69)
- Tumor Mutation Burden: Promises and Challenges A Perspective from the IASLC Pathology Committee. (2020) (68)
- Focal neuroendocrine differentiation lacks prognostic significance in prostate core needle biopsies. (1998) (67)
- Evaluation of NGS and RT‐PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project (2017) (66)
- EGF‐r gene copy number changes in renal cell carcinoma detected by fluorescence in situ hybridization (1998) (65)
- Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study (2019) (63)
- Immunocytochemistry for predictive biomarker testing in lung cancer cytology (2019) (63)
- Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient‐derived xenograft (PDX) models (2018) (62)
- Clinicopathological Characteristics of RET Rearranged Lung Cancer in European Patients (2016) (62)
- Intratumoral heterogeneity of von Hippel-Lindau gene deletions in renal cell carcinoma detected by fluorescence in situ hybridization. (1998) (61)
- Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer (2007) (58)
- Consistency and reproducibility of next‐generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens (2017) (58)
- A fluorescence in situ hybridization‐based assay for improved detection of lung cancer cells in bronchial washing specimens (2002) (55)
- Role of Fluorescence in situ Hybridization in Lung Cancer Cytology (2012) (55)
- The prognostic and predictive value of sstr2-immunohistochemistry and sstr2-targeted imaging in neuroendocrine tumors (2017) (55)
- Elevated levels of circulating IL-7 and IL-15 in patients with early stage prostate cancer (2011) (54)
- Early development of human lymphomas in a prostate cancer xenograft program using triple knock‐out Immunocompromised mice (2015) (53)
- ANXA7 expression represents hormone‐relevant tumor suppression in different cancers (2007) (52)
- Multiprobe Fluorescence in situ Hybridization (UroVysion) for the Detection of Urothelial Carcinoma – FISHing for the Right Catch (2011) (52)
- Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation (2012) (50)
- Gene profiling of clinical routine biopsies and prediction of survival in non-small cell lung cancer. (2010) (48)
- Advances in Brief Survey of Gene Amplifications during Prostate Cancer Progression by High-Throughput Fluorescence in Situ Hybridization on Tissue Microarrays 1 (1999) (47)
- Abundant expression of AMACR in many distinct tumour types (2006) (46)
- Variability in Diagnostic Opinion Among Pathologists for Single Small Atypical Foci in Prostate Biopsies (2010) (45)
- Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells. (2013) (44)
- Performances of two different panfungal PCRs to detect mould DNA in formalin-fixed paraffin-embedded tissue: what are the limiting factors? (2014) (44)
- Deep Clonal Profiling of Formalin Fixed Paraffin Embedded Clinical Samples (2012) (44)
- STAT5A/B gene locus undergoes amplification during human prostate cancer progression. (2013) (44)
- Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03. (2008) (43)
- p53 protein expression but not mdm-2 protein expression is associated with rapid tumor cell proliferation and prognosis in renal cell carcinoma (2004) (43)
- Prognostic Impact of ANX7-GTPase in Metastatic and HER2-Negative Breast Cancer Patients (2004) (42)
- Multitarget FISH analysis in the diagnosis of lung cancer. (2005) (42)
- Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project. (2017) (42)
- Lung Histology Predicts Outcome of Bronchiolitis Obliterans Syndrome after Hematopoietic Stem Cell Transplantation (2013) (40)
- Estrogen receptor β expression and androgen receptor phosphorylation correlate with a poor clinical outcome in hormone-naive prostate cancer and are elevated in castration-resistant disease. (2013) (40)
- DNA image cytometry and fluorescence in situ hybridization for noninvasive detection of urothelial tumors in voided urine (2002) (39)
- Scientific Advances in Thoracic Oncology 2016. (2017) (39)
- Amplification and overexpression of vinculin are associated with increased tumour cell proliferation and progression in advanced prostate cancer (2011) (38)
- VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: pooled analysis of SAKK19/05 and NTR528. (2013) (37)
- Global impact of the COVID‐19 pandemic on cytopathology practice: Results from an international survey of laboratories in 23 countries (2020) (37)
- ANX7 as a Bio-Marker in Prostate and Breast Cancer Progression (2002) (36)
- Ultrastructural and molecular analysis in fatal neonatal interstitial pneumonia caused by a novel ABCA3 mutation (2007) (36)
- Efficacy of Cetuximab in Metastatic Castration-Resistant Prostate Cancer Might Depend on EGFR and PTEN Expression: Results from a Phase II Trial (SAKK 08/07) (2012) (35)
- Genetic changes in clinically organ-confined prostate cancer by comparative genomic hybridization. (2000) (35)
- Leupaxin, a novel coactivator of the androgen receptor, is expressed in prostate cancer and plays a role in adhesion and invasion of prostate carcinoma cells. (2008) (35)
- Macrofollicular variant of papillary carcinoma of the thyroid: a histologic, cytologic, and immunohistochemical study of 3 cases and review of the literature. (2004) (35)
- A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape Project. (2019) (33)
- Prospective study of a panfungal PCR assay followed by sequencing, for the detection of fungal DNA in normally sterile specimens in a clinical setting: a complementary tool in the diagnosis of invasive fungal disease? (2013) (33)
- Comprehensive Molecular Characterization of Urothelial Bladder Carcinoma: A Step Closer to Clinical Translation? (2017) (33)
- Metastatic spread in patients with non-small cell lung cancer is associated with a reduced density of tumor-infiltrating T cells (2015) (33)
- Common Fluorescence In Situ Hybridization Applications in Cytology. (2016) (33)
- Quantitative proteomic and phosphoproteomic comparison of human colon cancer DLD-1 cells differing in ploidy and chromosome stability (2018) (33)
- Treatment and detection of ALK-rearranged NSCLC. (2013) (33)
- Combined transbronchial needle aspiration and positron emission tomography for mediastinal staging of NSCLC (2006) (33)
- Multitarget fluorescence in situ hybridization elucidates equivocal lung cytology. (2006) (32)
- DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH (2004) (32)
- Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: a multicenter phase II trial (SAKK 19/05). (2012) (31)
- Efficacy, safety, and biomarker results of trastuzumab emtansine (T-DM1) in patients (pts) with previously treated HER2-overexpressing locally advanced or metastatic non-small cell lung cancer (mNSCLC). (2017) (30)
- Nuclear and cytoplasmic Maspin expression in primary non-small cell lung cancer (2006) (30)
- Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. I. Molecular Biomarkers in Prostate Cancer (2020) (30)
- Lungscape: Resected Non–Small-Cell Lung Cancer Outcome by Clinical and Pathological Parameters (2014) (30)
- Deletion of the inhibitor of growth 4 (ING4) tumor suppressor gene is prevalent in human epidermal growth factor 2 (HER2)-positive breast cancer. (2011) (30)
- Prevalence and Clinical Outcomes for Patients With ALK Gene Rearrangement in Europe: Preliminary Results from the European Thoracic Oncology Platform Lungscape Project (2012) (30)
- Use of Lung Resection and Voriconazole for Successful Treatment of Invasive Pulmonary Aspergillus ustus Infection (2004) (30)
- Prognostic value of MIB-1 proliferation index in solitary fibrous tumors of the pleura implemented in a new score – a multicenter study (2017) (30)
- Detection of ROS1‐positive non‐small cell lung cancer on cytological specimens using immunocytochemistry (2018) (29)
- Intraductal carcinoma of prostate reporting practice: a survey of expert European uropathologists (2016) (29)
- Evaluation of chromosomal aberrations in patients with benign conditions and reactive changes in urinary cytology (2011) (29)
- Consistency and reproducibility of next‐generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens (2019) (29)
- MED12 overexpression is a frequent event in castration-resistant prostate cancer. (2014) (28)
- Predictive potential and need for standardization of PD-L1 immunohistochemistry (2018) (28)
- Donor‐derived, metastatic urothelial cancer after kidney transplantation associated with a potentially oncogenic BK polyomavirus (2018) (28)
- MED15, encoding a subunit of the mediator complex, is overexpressed at high frequency in castration‐resistant prostate cancer (2014) (28)
- PAGE4 positivity is associated with attenuated AR signaling and predicts patient survival in hormone-naive prostate cancer. (2012) (27)
- Detection rates of cancer, high grade PIN and atypical lesions suspicious for cancer in the European Randomized Study of Screening for Prostate Cancer. (2010) (27)
- Interobserver Variation among Pathologists and Refinement of Criteria in Distinguishing Separate Primary Tumors from Intrapulmonary Metastases in Lung (2017) (26)
- The Relevance of External Quality Assessment for Molecular Testing for ALK Positive Non-Small Cell Lung Cancer: Results from Two Pilot Rounds Show Room for Optimization (2014) (26)
- Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays’ and cross-validation with resections, in patients with, stage I–III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort (2019) (26)
- MET overexpression and gene amplification: prevalence, clinico-pathological characteristics and prognostic significance in a large cohort of patients with surgically resected NSCLC (2017) (25)
- Testing for anaplastic lymphoma kinase rearrangement to target crizotinib therapy: oncology, pathology and health economic perspectives (2013) (25)
- Clonal Evolution and Therapeutic Resistance in Solid Tumors (2013) (24)
- Memory CD8+ T Cells Balance Pro- and Anti-inflammatory Activity by Reprogramming Cellular Acetate Handling at Sites of Infection. (2020) (24)
- Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project (2018) (24)
- Glycine decarboxylase and HIF-1α expression are negative prognostic factors in primary resected early-stage non-small cell lung cancer (2017) (23)
- Combining bronchoscopy and positron emission tomography for the diagnosis of the small pulmonary nodule < or = 3 cm. (2005) (23)
- Loss of NKX 3 . 1 Expression in Human Prostate Cancers Correlates with Tumor Progression 1 , 2 (2000) (22)
- High NRBP1 expression in prostate cancer is linked with poor clinical outcomes and increased cancer cell growth (2012) (22)
- UroVysion multiprobe FISH in urinary cytology. (2004) (22)
- [EGFR mutation analysis in non-small-cell lung cancer : Experience from routine diagnostics]. (2009) (22)
- Correlation of ROS1 Immunohistochemistry With ROS1 Fusion Status Determined by Fluorescence In Situ Hybridization. (2020) (22)
- HPV L1 detection discriminates cervical precancer from transient HPV infection: a prospective international multicenter study (2013) (22)
- ERG rearrangement and protein expression in the progression to castration-resistant prostate cancer (2014) (22)
- [Diagnostic and predictive analyses of cytological specimens of non-small cell lung cancer: strategies and challenges]. (2013) (20)
- Does the Prostate Really Need Androgens to Grow? Transurethral Resection of the Prostate in a Male-to-Female Transsexual 25 Years after Sex-Changing Operation (2005) (20)
- Prognostic impact of KRAS G12C mutation in patients with NSCLC: results from the ETOP Lungscape Project. (2021) (20)
- Physical and transcript map of the hereditary prostate cancer region at xq27. (2002) (20)
- Morphological spot counting from stacked images for automated analysis of gene copy numbers by fluorescence in situ hybridization. (2002) (20)
- [Identification of prognostic parameters for renal cell carcinoma by cDNA arrays and cell chips]. (1999) (19)
- Compressed Sensing Radial Sampling MRI of Prostate Perfusion: Utility for Detection of Prostate Cancer. (2019) (19)
- Ciprofloxacin-induced acute interstitial pneumonitis (2004) (19)
- Prostate cancer patient‐derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens (2021) (19)
- Heterogeneity of ERG expression in core needle biopsies of patients with early prostate cancer. (2013) (18)
- Urothelial Cancer in Renal Transplant Recipients: Incidence, Risk Factors, and Oncological Outcome. (2016) (18)
- Assessment of mean EGFR gene copy number is a highly reproducible method for evaluating FISH in histological and cytological cancer specimens. (2010) (17)
- Narrative review of molecular pathways of kinase fusions and diagnostic approaches for their detection in non-small cell lung carcinomas (2020) (17)
- Lung resection in hematologic patients with pulmonary invasive fungal disease. (2012) (17)
- Analysis of AR/ARV7 Expression in Isolated Circulating Tumor Cells of Patients with Metastatic Castration-Resistant Prostate Cancer (SAKK 08/14 IMPROVE Trial) (2019) (16)
- Progressive pulmonary sarcoidosis--a fibroproliferative process potentially triggered by EGR-1 and IL-6. (2006) (16)
- UroVysion® multiprobe FISH in the triage of equivocal urinary cytology cases. (2012) (16)
- Identification of a MET-eIF4G1 translational regulation axis that controls HIF-1α levels under hypoxia (2018) (16)
- Targeted multiprobe fluorescence in situ hybridization analysis for elucidation of inconclusive pancreatobiliary cytology (2014) (16)
- CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo. (2020) (15)
- Delineation of human prostate cancer evolution identifies chromothripsis as a polyclonal event and FKBP4 as a potential driver of castration resistance (2018) (15)
- Differential Patterns of Large Tumor Antigen-Specific Immune Responsiveness in Patients with BK Polyomavirus-Positive Prostate Cancer or Benign Prostatic Hyperplasia (2012) (15)
- Molecular testing in stage I-III non-small cell lung cancer: Approaches and challenges. (2021) (15)
- ERG rearrangement in local recurrences compared to distant metastases of castration-resistant prostate cancer (2012) (15)
- Consistency of prostate cancer grading results in screened populations across Europe (2003) (14)
- Bevacizumab, Pemetrexed, and Cisplatin, or Bevacizumab and Erlotinib for Patients With Advanced Non-Small-Cell Lung Cancer Stratified by Epidermal Growth Factor Receptor Mutation: Phase II Trial SAKK19/09. (2015) (14)
- Cytology of SMARCA4-Deficient Thoracic Neoplasms: Comparative Analysis of SMARCA4-Deficient Non-Small Cell Lung Carcinomas and SMARCA4-Deficient Thoracic Sarcomas (2020) (14)
- EGFR and IGF‐1R in regulation of prostate cancer cell phenotype and polarity: opposing functions and modulation by T‐cadherin (2015) (14)
- The Paris System for reporting urinary cytology in daily practice with emphasis on ancillary testing by multiprobe FISH (2019) (14)
- Culture and Drug Profiling of Patient Derived Malignant Pleural Effusions for Personalized Cancer Medicine (2016) (14)
- Making Cytological Diagnoses on Digital Images Using the iPath Network (2014) (13)
- Patterns of stemness-associated markers in the development of castration-resistant prostate cancer. (2020) (13)
- Molecular pathology of prostate cancer: a practical approach. (2020) (13)
- Gigapixel fluorescence microscopy with a water immersion microlens array (2013) (13)
- A noninterventional, multinational study to assess PD‐L1 expression in cytological and histological lung cancer specimens (2020) (12)
- MED15 overexpression in prostate cancer arises during androgen deprivation therapy via PI3K/mTOR signaling (2016) (12)
- Application of personalized medicine to solid tumors: opportunities and challenges. (2012) (12)
- Robust assessment of tumor mutational burden in cytological specimens from lung cancer patients. (2020) (12)
- PD-L1 testing of non-small cell lung cancer using different antibodies and platforms: a Swiss cross-validation study (2019) (12)
- Immunocytochemistry for ARID1A as a potential biomarker in urine cytology of bladder cancer (2019) (11)
- EGFR Exon-Level Biomarkers of the Response to Bevacizumab/Erlotinib in Non-Small Cell Lung Cancer (2013) (11)
- PLCγ1 suppression promotes the adaptation of KRAS-mutant lung adenocarcinomas to hypoxia (2020) (11)
- [Non-small cell lung cancer. Subtyping and predictive molecular marker investigations in cytology]. (2012) (11)
- Lonely Driver ROS1. (2017) (11)
- Follow-up in non-small-cell lung cancer (2014) (10)
- [Molecular pathological diagnosis in cytopathology of non-small-cell lung cancer. Standardization of specimen processing]. (2013) (10)
- Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression (2021) (10)
- Deciphering the clonal relationship between glandular and squamous components in adenosquamous carcinoma of the lung using whole exome sequencing. (2020) (10)
- Extraction of high‐integrity RNA suitable for microarray gene expression analysis from long‐term stored human thyroid tissues (2006) (10)
- Can molecular markers stratify the diagnostic value of high-grade prostatic intraepithelial neoplasia? (2011) (10)
- An online quiz uncovers limitations of morphology in equivocal lung cytology (2006) (10)
- 2nd ESMO Consensus Conference on Lung Cancer : non-small-cell lung cancer first-line/second and further lines in advanced disease (2014) (9)
- Resection of isolated brain metastases in non-small cell lung cancer (NSCLC) patients – evaluation of outcome and prognostic factors: A retrospective multicenter study (2021) (9)
- A phase I study of doxorubicin-loaded anti-EGFR immunoliposomes in patients with advanced solid tumors. (2011) (9)
- Loss of ANXA7 Expression is Associated with Poor Patient Survival in Ovarian Cancer (2011) (9)
- OA03.03 Phase 2B of Blueprint PD-L1 Immunohistochemistry Assay Comparability Study (2018) (9)
- Genomic testing among patients with newly diagnosed advanced non-small cell lung cancer in the United States: A contemporary clinical practice patterns study. (2022) (8)
- Abstract 5386: Immunotherapy of bladder cancer using bacillus calmette guérin (BCG): Generation of cytotoxic T-cells is BCG strain dependent (2012) (8)
- Maximum tumor diameter adjusted to the risk profile predicts biochemical recurrence after radical prostatectomy (2014) (8)
- Incidental prostate cancer prevalence at radical cystoprostatectomy—importance of the histopathological work-up (2014) (8)
- Genomic analysis and selected molecular pathways in rare cancers (2012) (8)
- [Molecular genetics of urinary bladder cancer progression]. (2002) (8)
- T‐cadherin in prostate cancer: relationship with cancer progression, differentiation and drug resistance (2016) (8)
- ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib. (2019) (7)
- How technology is reshaping the practice of nongynecologic cytology (2007) (7)
- Bronchoalveolar lavage quality influences the T4/T8 ratio in sarcoidosis. (2007) (7)
- [Cytology of the urinary tract: Between uncertainty and clarity]. (2009) (7)
- [Fluorescence in situ hybridization. A new diagnostic dimension in cytology]. (2007) (7)
- Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future (2020) (7)
- Exploring the spatiotemporal genetic heterogeneity in metastatic lung adenocarcinoma using a nuclei flow‐sorting approach (2019) (7)
- A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non–muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14 (2022) (6)
- Prediction of outcome in patients with low‐grade squamous intraepithelial lesions by fluorescence in situ hybridization analysis of human papillomavirus, TERC, and MYC (2013) (6)
- Informative value of histological assessment of tissue acquired during aquablation of the prostate (2020) (6)
- Potential consequences of low biopsy core number in selection of patients with prostate cancer for current active surveillance protocols. (2013) (6)
- Handling and reporting of pelvic lymphadenectomy specimens in prostate and bladder cancer: a web‐based survey by the European Network of Uropathology (2019) (6)
- COVID‐19 pandemic impact on cytopathology practice in the post‐lockdown period: An international, multicenter study (2022) (6)
- Stat 5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo (2010) (6)
- Interstitial Lung Disease in an Intravenous Drug User (2003) (6)
- Computer‐Based Intensity Measurement Assists Pathologists in Scoring Phosphatase and Tensin Homolog Immunohistochemistry — Clinical Associations in NSCLC Patients of the European Thoracic Oncology Platform Lungscape Cohort (2018) (6)
- Mesothelioma after lung transplantation (2006) (6)
- Chemotherapy negatively impacts the tumor immune microenvironment in NSCLC: an analysis of pre- and post-treatment biopsies in the multi-center SAKK19/09 study (2020) (6)
- [Genomic changes in urinary bladder cancer]. (1997) (6)
- Fluoreszenz-in-situ-Hybridisierung (2007) (6)
- IASLC Global Survey on PD-L1 Testing for Non-Small Cell Lung Cancer. (2021) (6)
- Alterations in homologous recombination repair genes in prostate cancer brain metastases (2022) (5)
- Challenges in the Diagnosis of NTRK Fusion-Positive Cancers. (2020) (5)
- [Cytology in the internet]. (2007) (5)
- MED 12 overexpression is a frequent event in castration-resistant prostate cancer (2014) (5)
- Tissue microarray analysis delineate potential prognostic role of Annexin A7 in prostate cancer progression (2018) (5)
- Tissue Microarrays Meet Cytopathology (2006) (5)
- The Genomic Landscape of Prostate Cancer Brain Metastases (2020) (5)
- Glutathione S‐transferase‐pi protein expression in prostate cancer–not always a useful diagnostic tool (2015) (4)
- Fluorescence in situ hybridization in the diagnosis of urothelial carcinoma. (2010) (4)
- Montelukast and Churg-Strauss syndrome. (2004) (4)
- [Preneoplastic lesions of pulmonary carcinoma]. (2011) (4)
- Genomic testing among patients (pts) with newly diagnosed advanced non-small cell lung cancer (aNSCLC) in the United States: A contemporary clinical practice patterns study. (2020) (4)
- TargetPlex FFPE-Direct DNA Library Preparation Kit for SiRe NGS panel: an international performance evaluation study (2021) (4)
- Sensitive detection methods are key to identify secondary EGFR c.2369C>T p.(Thr790Met) in non-small cell lung cancer tissue samples (2020) (4)
- Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08) (2019) (4)
- Words of wisdom. Re: Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. (2009) (4)
- Abstract 655: Development of IHC staining protocols for assessment of PD-L1 expression in cytological samples (2017) (4)
- Contralateral recurrence of a malignant solitary fibrous tumor of the pleura. (2011) (4)
- Putative Malignant Pleural Mesothelioma in situ (MPMIS) with Sequential Acquisition of Genomic Alterations on Fluorescence in situ Hybridization (FISH) Examination (2020) (3)
- Editorial comment on: the value of the UroVysion assay for surveillance of non-muscle-invasive bladder cancer. (2008) (3)
- Diagnostic accuracy and clinical implications of robotic assisted MRI-US fusion guided target saturation biopsy of the prostate (2021) (3)
- Ceramic foam plates: a new tool for processing fresh radical prostatectomy specimens (2014) (3)
- [Prostate cancer. Part 2: Review of the various tumor grading systems over the years 1966-2015 and future perspectives of the new grading of the International Society of Urological Pathology (ISUP)]. (2016) (3)
- Can cytology reliably subtype non‐small cell lung carcinomas? (2021) (3)
- The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLC (3)
- Influence of hematuria and infection on diagnostic accuracy of urinary LASP1: a new biomarker for bladder carcinoma. (2017) (3)
- EVALUATION OF PROGNOSTIC MARKERS IN URINARY BLADDER CANCER USING TUMOR TISSUE ARRAYS (1999) (3)
- Three Genes to Predict Response to Chemotherapy for Bladder Cancer: Individualised Cancer Care at the Doorstep. (2015) (3)
- Bevacizumab (B) and erlotinib (E) as first-line therapy in metastatic nonsquamous non-small cell lung cancer (NSCLC) followed by platinum-based chemotherapy (CT) at disease progression (PD): A multicenter phase II trial, SAKK 19/05. (2011) (3)
- Urinary Calprotectin loses specificity as tumour marker due to sterile leukocyturia associated with bladder cancer (2019) (3)
- Somatic Features of Response and Relapse in Non–muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin Immunotherapy (2021) (3)
- Cytologically targeted next-generation sequencing: a synergy for diagnosing urothelial carcinoma. (2020) (3)
- [The Paris system for classification of urinary cytology]. (2017) (3)
- [The pathology of adverse events with immune checkpoint inhibitors]. (2017) (3)
- HIGH-THROUGHPUT SURVEY OF GENE AMPLIFICATIONS UNDERLYING PROSTATE CANCER PROGRESSION USING A NOVEL TISSUE MICROARRAY ("TISSUE CHIP") TECHNOLOGY (1999) (3)
- Rapidly growing intrathoracic mass with paraneoplastic syndrome. (1996) (2)
- Plasma Osteopontin Is a Biomarker Specifically Associated with Bronchiolitis Obliterans Syndrome after HCT (2016) (2)
- An Unexpected Cause of Diffuse Alveolar Hemorrhage in a Kidney Transplant Patient (2014) (2)
- Non-small cell lung carcinoma subtyping in conventional cytology: Results of the IASLC Cytology Working Group survey to determine specific cytomorphological criteria for adenocarcinoma and squamous cell carcinoma. (2022) (2)
- [Atypical urothelial cells in the urine]. (2010) (2)
- Ancillary Studies in Urinary Cytology (2022) (2)
- ANXA7 Expression has Prognostic Impact for Patient Survival In Triple Negative Breast Cancers (2011) (2)
- COVID-19 Pandemic effect on Cytopathology Practice: Results from 23 Laboratories in 11 Countries (2020) (2)
- Prevalence and clinical association of MET gene amplification in patients with NSCLC: results from the ETOP lungscape project (2015) (2)
- Non-small cell lung cancer, early stage (2012) (2)
- Genomic evolutionary trajectory of metastatic squamous cell carcinoma of the lung (2021) (2)
- P2.09-24 IASLC Global Survey for Pathologists on PD-L1 Testing for Non-Small Cell Lung Cancer (2019) (2)
- B7-03: Prediction of major NSCLC tumor classes and clinical outcome by functional genomics of small bronchoscopic tumor biopsies (2007) (2)
- Macrofollicular Variant of Papillary Carcinoma of the Thyroid (2004) (2)
- Moving Towards Minimally Invasive Genomically Based Diagnosis and Monitoring of Bladder Cancer. (2016) (2)
- Deciphering the genetic landscape of pulmonary lymphomas (2020) (2)
- There is more than meet the eyes in head and neck cytopathology (2014) (2)
- Extensive Emperipolesis of Neoplastic Lymphocytes by Mesothelial Cells in Pleural Effusion Cytology in a Case of a Mediastinal T-Cell Lymphoblastic Lymphoma: A Rare but Diagnostically Useful Phenomenon (2019) (2)
- The Role of Fluorescence in Situ Hybridization for Predicting Recurrence after Adjuvant Bacillus Calmette-Guérin in Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer Patients: A Systematic Review and Meta-Analysis of Individual Patient Data. (2020) (2)
- TRANSCRIPTION FACTOR STAT5 SYNERGIZES WITH ANDROGEN RECEPTOR IN PROSTATE CANCER CELLS (2008) (2)
- External Quality Assessment for ALK Immunohistochemistry Testing in Lung Adenocarcinoma Within the European Thoracic Oncology Platform Lungscape Project (2012) (2)
- Tumor mutational burden assessed by a targeted NGS assay predicts clinical benefit from immune checkpoint inhibitors in non-small cell lung cancer. (2018) (1)
- Low-Grade Papillary Urothelial Carcinoma, Cytological Findings (2017) (1)
- High Inter- and Intratumoral Variability of Ki67 Labeling Index in Newly Diagnosed Prostate Cancer with High Gleason Scores (2021) (1)
- Disease specific effects of adrenomedullin in COPD and asthma derived human bronchial epithelial cells (2015) (1)
- [Urinary cytology after renal transplantation]. (2006) (1)
- TRANSCRIPTION FACTOR STAT3 PROMOTES METASTATIC PROGRESSION OF PROSTATE CANCER (2008) (1)
- MOLECULAR MECHANISMS UNDERLYING ENDOCRINE THERAPY FAILURE IN HUMAN PROSTATE CANCER ANALYZED BY DNA AND TISSUE MICROARRAYS (1999) (1)
- Primary endpoints to assess the efficacy of novel therapeutic approaches in epidermal growth factor receptor-mutated, surgically resectable non-small cell lung cancer: A review. (2023) (1)
- Results of a phase II single arm clinical trial assessing efficacy, safety and tolerability of the recombinant Bacillus Calmette Guérin (BCG) VPM1002BC in patients with BCG failure - SAKK 06/14 (2020) (1)
- [Pleural mesothelioma. Cytology and molecular diagnostics]. (2014) (1)
- [Prostate cancer. Part 1: Review of cell kinetics over the years 1966-2015 and future perspectives of the new grading of the International Society of Urological Pathology (ISUP)]. (2016) (1)
- EGFR-gene analysis on cytological specimens of non-small-cell lung cancers (2007) (1)
- [Alveolocapillary microaneurysm in p-ANCA positive microvasculitis (microform of panarteritis nodosa)]. (1995) (1)
- 3001 Prevalence and clinical association of gene mutations through Multiplex Mutation Testing in patients with NSCLC: Results from the ETOP Lungscape Project (2015) (1)
- [Molecular pathology of urogenital tumors : Recommendations from the 2019 International Society of Urological Pathology (ISUP) Consensus Conference]. (2021) (1)
- 410 Early development of human lymphomas in a prostate cancer xenograft program using triple knock-out immunocompromised mice (2015) (1)
- Prevalence and clinical associations of PTEN loss in non-small cell lung carcinoma (NSCLC) patients (pts) of the European Thoracic Oncology Platform (ETOP) Lungscape cohort (2016) (1)
- Dysplastic cells in cytological cervical samples show a high incidence of chromosomal abnormalities (2009) (1)
- Prognostic Impact of ANX 7-GTPase in Metastatic and HER 2-Negative Breast Cancer Patients (2004) (1)
- 319 COMPREHENSIVE ANALYSIS OF THE TMPRSS2-ERG TRANSLOCATION DURING PROSTATE CANCER PROGRESSION (2012) (1)
- Oncogenic potential of KCNMA1 in prostate cancer. (2004) (1)
- Protocols for Tissue Microarrays in Prostate Cancer Studies. (2018) (1)
- HIGH-THROUGHPUT TISSUE MICROARRAY ANALYSIS TO EVALUATE PROGNOSTIC SIGNIFICANCE OF GENES UNCOVERED BY cDNA MICROARRAY SCREENING (1999) (1)
- Diagnose und prädiktive Analysen an zytologischen und bioptischen Tumorproben nicht-kleinzelliger Lungenkarzinome: Aktuelle Strategien und Herausforderungen (2013) (1)
- Abstract 250: Vinculin is a putative amplification target gene at 10q22 in advanced prostate cancer (2010) (1)
- P1.01-04 Treatment Patterns and Overall Survival Following Biomarker Testing in Real-World Advanced NSCLC Patients (2018) (1)
- Exonic expression variations of EGFR and KRAS in small bronchoscopic biopsies from patients with advanced non-small cell lung cancer treated by combined bevacizumab/erlotinib therapy followed by platinum-based chemotherapy at disease progression: A multicenter phase II trial SAKK19/05. (2011) (1)
- PD-L 1 testing of non-small cell lung cancer using different antibodies and platforms : a Swiss cross-validation study (2019) (1)
- Das Paris-System zur Klassifikation der Urinzytologie (2017) (1)
- P3.01-021 Reproducibility of Comprehensive Histologic Assessment and Refining Histologic Criteria in P Staging of Multiple Tumor Nodules: Topic: Morphology (2017) (1)
- Defining morphologic features of invasion in pulmonary non-mucinous adenocarcinoma with lepidic growth - A proposal by the IASLC Pathology Committee. (2022) (1)
- Prevalence and clinical correlation of programmed cell death 1 ligand (PD-L1) expression in patients with resected non-small cell lung cancer (NSCLC): Results from the European Thoracic Oncology Platform (ETOP) Lungscape cohort. (2017) (1)
- MA 15.11 CCNE1, PTGS2, TGFA and WISP2 Predict Benefit from Bevacizumab and Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer (SAKK19/09) (2017) (1)
- Identification of genes involved in hormone-independent prostate cancer by cDNA microarrays, followed by in vivo analysis of selected genes using tissue microarray analysis (1999) (1)
- Gene expression changes during hormonal therapy for prostate cancer reveal candidate diagnostic and drug targets (2001) (1)
- Suppl. Table S1 (2011) (1)
- Patterns of stemness‐associatedmarkers in the development of castration‐resistant prostate cancer (2020) (1)
- Molecular oncology in lung cancer – between biomarkers and clinical application. Relevance of the Ras–Raf–MEK–ERK pathway (2011) (1)
- Molecular pathology of the prostate carcinoma. Academic playground or guide for diagnosis or therapy planning (2004) (1)
- CHAPTER 36 – Molecular Techniques (2008) (1)
- Diagnostic value of cryobiopsy in patients with interstitial lung diseases integrating bronchoalveolar lavage, radiologic and clinical data (2020) (1)
- Current Awareness on Comparative and Functional Genomics (2004) (1)
- Abstract 4562: Comprehensive analysis of theTMPRSS2-ERGtranslocation during prostate cancer progression (2012) (1)
- Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08) (2019) (1)
- Computer-based intensity measurement assists pathologists in scoring PTEN immunohistochemistry - Clinical associations in NSCLC patients of the ETOP Lungscape cohort (2019) (0)
- Development of novel prostate cancer patient-derived models and applications for translational research (2021) (0)
- non-small cell lung cancer, early stage 1179O THE EUROPEAN THORACIC ONCOLOGY PLATFORM LUNGSCAPE PROJECT: A WAY TO BRIDGE NON-SMALL CELL LUNG CANCER MOLECULAR CHARACTERISTICS AND CLINICAL DATA (2012) (0)
- Current Awareness on Comparative and Functional Genomics (2005) (0)
- Ancillary Studies for Serous Fluids (2020) (0)
- Abstract 2184: Enrichment and isolation of tumor cells using a unique flow-sorting approach to decrypt intratumoral heterogeneity in matched samples of squamous cell carcinoma of the lung (2018) (0)
- Report on Norrie’s cytology (2012) (0)
- Abstract 4681: The use of patient derived malignant effusions asin vitromodels for a personalized healthcare-approach in anticancer therapy (2014) (0)
- [Cytopathology is alive!]. (2007) (0)
- Bladder Wash Specimen (2017) (0)
- Application of personalised medicine to solid tumours: opportunities and challenges (2012) (0)
- Influence of Different Components of the Tumor Microenvironment on Human Patient-Derived Lymphoma Cell Engraftment in Immmunodeficient Mice (2015) (0)
- Abstract 158: Clonal evolution and genomic tumor heterogeneity in non-small cell lung cancer deciphered by multiparameter ploidy profiling (2016) (0)
- Human Polyomavirus, Cytological Findings (2017) (0)
- MP05-03 ROBOTIC ASSISTED MRI-US FUSION GUIDED TARGET SATURATION BIOPSY OF THE PROSTATE; DIAGNOSTIC ACCURACY AND CLINICAL IMPLICATIONS (2021) (0)
- Contents Vol. 56,2012 (2012) (0)
- 4P Prevalence of MET exon 14-mutations or MET amplification in non-small cell lung cancer in Swiss patients (2021) (0)
- [Multiprobe FISH for enhanced prediction of recurrent bladder cancer]. (2004) (0)
- Urovysion fish assay for non-invasive detection of bladder tumors in urinary specimens (2002) (0)
- MED12 Is a Potential Target for Therapeutic Intervention in Castration Resistant Prostate Cancer (2014) (0)
- Cytogenetics of Prostate Cancer (2003) (0)
- 15P The genomic landscape of pleomorphic lung cancer using whole exome sequencing (2021) (0)
- Guidelines for processing and reporting of prostatic (2003) (0)
- Modern Methods in Cytology, Abstract 271–276, Symposium (2003) (0)
- 01: PD-L1 testing using concentrated 22C3 antibody: Results of the Swiss cross-validation study (2017) (0)
- Abstract 3815: Stage I non-small cell lung cancer expressing SOX2 show more recurrence in elderly male patients with non-adenocarcinoma histology (2011) (0)
- needle biopsies Guidelines for processing and reporting of prostatic (2006) (0)
- Identification and use of treatment (tx) options in patients (pts) with advanced non-small cell lung cancer (aNSCLC) after comprehensive genomic profiling (CGP): A real-world study. (2019) (0)
- Abstract 1082: The amplification and overexpression of the calcium activated chloride channel TMEM16A (aka DOG1) has a prognostic role in patients with head and neck squamous cell carcinoma (2011) (0)
- Abstract 2124: Comprehensive analysis of hormone receptor status during prostate cancer progression: A novel prognostic role for pAR and ERbeta (2011) (0)
- [Cytopathology-an introduction to the subject]. (2022) (0)
- Subject Index Vol. 56,2012 (2012) (0)
- DNA Methylation Landscapes of Prostate Cancer Brain Metastasis Are Shaped by Early Driver Genetic Alterations (2023) (0)
- Der besondere Fall: Reversed Halo Sign (2005) (0)
- A novel patient-derived model to study cellular plasticity and drug response in sarcomatoid urothelial bladder cancer (2022) (0)
- SIGNIFICANCE OF HIGH-GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA AND ATYPICAL FOCI SUSPICIOUS FOR CARCINOMA IN THE SCREENING POPULATION IN THE FIRST AND SECOND ROUND OF SCREENING (2008) (0)
- [Prostatic carcinoma: from morphology to molecular biology]. (2003) (0)
- Contents Vol. 87, 2014 (2014) (0)
- Rapid analysis of gene copy numbers in cancer by FISH and automated spot counting from stacked confocal images (2000) (0)
- P2.04-14 Tumor Mutational Burden Assessed by a Targeted NGS Assay Predicts Benefit from Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (2018) (0)
- Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study (2019) (0)
- Robotic assisted MRI-US fusion guided target saturation biopsy of the prostate – preliminary results for diagnostic accuracy and clinical implications (2021) (0)
- suppl Figure 1 (2016) (0)
- LSC Abstract – System biology of adrenomedullin is controlled via its cell type specific expressed receptors in the human lung (2016) (0)
- Abstract 4924: Multiparameter ploidy profiling: a powerful tool to investigate the genomics of diploid tumor populations (2015) (0)
- Diagnostic surgical lung biopsy in hematologic patients with pulmonary complications (2011) (0)
- Abstract 556: L-Tag-driven systemic immune regulatory profile as a potential signature for polyomavirus BK involvement in prostate cancer (2012) (0)
- Survey of gene expression during prostate cancer progression using tissue microarrays (2003) (0)
- High-Grade Urothelial Carcinoma, Cytological Findings (2017) (0)
- Chapter 4 BPH, PSA, and the risk of having prostate cancer (PCA) (2011) (0)
- Assessment of RANK/RANK-L prevalence and clinical significance in NSCLC European Thoracic Oncology Platform Lungscape cohort and SPLENDOUR randomized clinical trial. (2022) (0)
- Integration of transbronchial cryobiopsy into multidisciplinary board decision: a single center analysis of one hundred consecutive patients with interstitial lung disease (2021) (0)
- Amplification of KCNMA 1 : A Potential Therapeutic Target in Prostate Cancer (2007) (0)
- 1OROS1 immunocytochemistry on cytological specimens in patients with non-small cell lung cancer (2017) (0)
- 640 Looking for a stemness signature in prostate cancer (2010) (0)
- 143 MED15 overexpression arises during androgen deprivation therapy via PI3K/mTOR signaling (2016) (0)
- 48 Amplification and overexpression of vinculin are associated with increased tumour cell proliferation and progression in advanced prostate cancer (2010) (0)
- [Cytological material for molecular pathology]. (2015) (0)
- Immunohistochemical markers in HGPIN immunohistochemical markers can reproducibly stratify the risk of prostate cancer after a diagnosis of isolated high-grade prostatic intraepithelial neoplasia (2011) (0)
- 52PMULTIPARAMETER PLOIDY PROFILING: A POWERFUL TOOL TO INVESTIGATE THE GENOMICS OF DIPLOID TUMOR POPULATIONS (2015) (0)
- P3.04-009: Evaluation of RT-PCR Methodology for ALK Assessment in Patients with NSCLC in Europe: Results from the ETOP Lungscape Project (2015) (0)
- Lung biopsy predicts outcome in bronchiolitis obliterans following allogeneic stemcell transplantation (2011) (0)
- 945 The genomic evolution of prostate cancer under the selective pressure of anti-androgen therapy (2013) (0)
- [Urinary cytology and molecular markers]. (2010) (0)
- FISH for evaluation of uncertain atypia in lung cytology (2004) (0)
- Urine Specimen Cytology (2017) (0)
- Abstract 1493: The clonal relationship between adenomatous and squamous components in adenosquamous carcinoma of the lung (2020) (0)
- 36 castration-resistant prostate cancer (2016) (0)
- Tumorigenesis and Neoplastic Progression Stat 3 Promotes Metastatic Progression of Prostate Cancer (2010) (0)
- ETOP activity in the field of biomarkers and predictors (2012) (0)
- Exploiting single-cell RNA sequencing data to optimize prostate cancer patient-derived organoid models (2022) (0)
- Anti-KCNMA1 siRNA: effect on growth rate and phenotype of the prostata carcinoma cell line PC-3 (2004) (0)
- EXPRESSION OF IDO IMMUNOSUPPRESSIVE FACTOR GENE AND MALIGNANT TRANSFORMATION IN PROSTATE CANCER (2008) (0)
- 1630PDAssociation of programmed cell death 1 ligand (PD-L1) expression with molecular alterations in non-small cell lung cancer (NSCLC) patients (pts): Results from the European Thoracic Oncology Platform (ETOP) Lungscape cohort (2017) (0)
- Abstract 3073: Bladder cancer patient-derived organoids to decipher cellular plasticity and cancer progression (2022) (0)
- 1287PDPreoperative chemotherapy and radiotherapy concomitant to cetuximab in stage IIIB NSCLC: A multicenter phase II SAKK (2017) (0)
- Visioning - Evaluation of a solely MRI-based, PSA-free prostate cancer screening program (2021) (0)
- MA12.07 Defining Morphologic Features of Invasion in Pulmonarynon-Mucinousadenocarcinoma with Lepidic Growth (2022) (0)
- PUB041 HGF, VEGFA and ANGPT2 Predict Clinical Benefit from Bevacizumab and Chemotherapy in Patients with Advanced NSCLC (SAKK19/09) (2017) (0)
- MA17.02 Genome-Wide Copy Number and Mutational Analysis in Longitudinal Biopsies of Matched Primary and Metastatic Pulmonary Adenocarcinomas (2017) (0)
- Toward the development of clinically relevant ex vivo models of prostate cancer (2018) (0)
- Lamellar Inclusions within Hyperplastic Endoplasmic Reticulum in Benign Mesothelial Cells (2020) (0)
- Abstract 3181: The genomic evolution of prostate cancer under the selective pressure of anti-androgen therapy. (2013) (0)
- Abstract 2515: Comprehensive analysis of the histologically distinct components of an adenosquamous carcinoma of the lung (2019) (0)
- Characteristics of circulating tumor cells (CTCs) in patients with lung cancer: 26P (2016) (0)
- 6 Cancer-testis antigens as potential targets for specific immunotherapy in prostate cancer (2014) (0)
- Autophagy in early stage NSCLC – prognostic significance of the autophagy markers p 62 and LC 3 (2016) (0)
- Abstract A206: Clinically relevant perspectives of the clonal nature of cancer (2009) (0)
- Abstract 155: The analysis of the genomic evolution of squamous cell carcinoma of the lung (2016) (0)
- The landscape of stemness-associated markers in the development of castration-resistant prostate cancer (2019) (0)
- The World Health Organization Reporting System for Lung Cytopathology (2022) (0)
- P1.08-065 Resection of Isolated Brain Metastasis Improves Outcome of Non-Small-Cell Lung Cancer (NSCLC) Patients: A Retrospective Multicenter Study: Topic: Surgery for Locally Advanced and Advanced NSCLC (2017) (0)
- IBS08.01 Harmonization of PD-L1 IHC Including LDT (2019) (0)
- In Memoriam - A Tribute to Alexander Meisels (1926-2014) (2014) (0)
- Antitumor activity of MEK and PI3K inhibitors in malignant pleural mesothelioma (2011) (0)
- Anaplastic lymphoma kinase 1 detected by immunohistochemistry in non-small cell lung cancer: a promising feature? (2010) (0)
- Abstract 3178: Metastatic urothelial cancer 10 years after transplanting a filial kidney: genomically investigating the perpetrator (2016) (0)
- Alveolar herniation in transbronchial lung biopsy: a newly recognised diagnostic pitfall (2018) (0)
- Unexpected Intracameral Foreign Body during Routine Cataract Surgery (2017) (0)
- [Cytogenetic changes in prostatic carcinoma]. (1998) (0)
- HyperplasiaCancer or Benign Prostatic in Patients with BK Polyomavirus-Positive Antigen-Specific Immune Responsiveness Differential Patterns of Large Tumor (2012) (0)
- 433 High NRBP1 expression in prostate cancer is associated with poor clinical outcomes and increased cancer cell growth (2012) (0)
- A Prospective Multicenter Study for ALK IHC plus Metastasized NSCLC (2015) (0)
- Current Awareness on Comparative and Functional Genomics (2002) (0)
- 830 LOOKING FOR A STEMNESS SIGNATURE IN PROSTATE CANCER (2011) (0)
- P1.02-025 Evaluation of NGS and RT-PCR Methods for ALK Assessment in European NSCLC Patients: Results from the ETOP Lungscape Project: Topic: Driver Genes in NSCLC, Resistance, and Other (2017) (0)
- Why Cytology for Molecular Testing? Pros and Cons (2018) (0)
- Epigenetic deregulated translation control of C/EBP-alpha leads to increased mesothelioma cell proliferation (2011) (0)
- Abstract 820: Genome-wide aberration analysis of rare cancer cell populations derived from formalin fixed paraffin embedded tissue. (2013) (0)
- 986: Multiprobe-Fluorescence in Situ Hybridization for Better Prediction of Recurrent Bladder Cancer (2006) (0)
- 627: MED12 overexpression is a frequent event in castration-resistant prostate cancer (2014) (0)
- Somatic features of response and relapse in non-muscle invasive bladder cancer treated with intravesical Bacillus Calmette–Guérin (2021) (0)
- Advancing patient-derived organoids of prostate cancer for disease modeling and personalized medicine (2020) (0)
- Abstract 3423: The genomic evolution of prostate cancer under the selective pressure of anti-androgen therapy (2014) (0)
- Survey of genetic alterations during prostate cancer progression (2000) (0)
- A novel patient-derived model of sarcomatoid urothelial bladder cancer (2021) (0)
- Swiss Pathology Days (2017) (0)
- Autophagy in early stage NSCLC – prognostic significance of the autophagy markers p62 and LC3B: 25P (2016) (0)
- Abstract 4699: Enriching tumor purity using a unique flow-sorting approach to elucidate clonal evolution in matched samples of squamous cell carcinoma of the lung (2019) (0)
- Robotic Assisted MRI-US Fusion Guided Target Saturation Biopsy of the Prostate – Diagnostic Accuracy and Clinical Implications (2021) (0)
- [Molecular pathology of prostate carcinoma. Academic playground or guide for diagnosis and therapy planning?]. (2004) (0)
- Prognostic impact of tumour mutational burden in resected stage I and II lung adenocarcinomas from a European Thoracic Oncology Platform Lungscape cohort. (2022) (0)
- 1199PDPREVALENCE AND CLINICAL OUTCOMES FOR PATIENTS WITH MET PROTEIN EXPRESSION IN PATIENTS WITH NON-SMALL CELL LUNG CANCER IN EUROPE: RESULTS FROM THE EUROPEAN THORACIC ONCOLOGY PLATFORM LUNGSCAPE PROJECT. (2014) (0)
- Urothelial Carcinoma, Cytological Findings (2017) (0)
- Abstract 3424: Deciphering the genomic heterogeneity and evolution in malignant melanoma by genomic profiling of clonal tumor populations (2014) (0)
- Abstract 3167: Deciphering the genomic heterogeneity in malignant melanoma by genomic profiling of clonal tumor populations. (2013) (0)
- Delineation of human prostate cancer evolution identifies chromothripsis as a polyclonal event selecting for FKBP4 driven castration resistance (2017) (0)
- Figure 4, [Type 4 decoy cells with...]. (2013) (0)
- Protein expression profiling in prostate cancer using tissue micro-arrays (2002) (0)
- 394 SIGNIFICANCE OF HIGH-GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA AND ATYPICAL FOCI SUSPICIOUS FOR CARCINOMA IN THE SCREENING POPULATION (2009) (0)
- Advances in Brief Intratumoral Heterogeneity of Von Hippel-Lindau Gene Deletions in Renal Cell Carcinoma Detected by Fluorescence in Situ Hybridization 1 (2006) (0)
- Abstract 3658: The expression of genes encoding common gamma-chain cytokines is associated with tissue infiltration by CD8+ T cells displaying an “exhausted” phenotype in benign prostatic hyperplasia and prostate cancer (2011) (0)
- Can cytology differentiate Norrie's disease from Retinoblastoma? (2010) (0)
- P2.02-024 False Positivity Due to Polysomy in Fluorescence in Situ Hybridization (2017) (0)
- Genome Scanning and Tissue Microarrays for the Analysis of Molecular Mechanisms Underlying Hormone Therapy Failure in Prostate Cancer (2001) (0)
- Establishment and characterization of two novel patient-derived organoid xenograft models of advanced prostate cancer (2022) (0)
- Strong COX-2-expression in hormone-refractory and metastatic prostate cancer — a potential therapeutic target (2004) (0)
- MA 06.06 Assessment of RANK Prevalence and Clinical Significance in the NSCLC European Thoracic Oncology Platform Lungscape Cohort (2017) (0)
- 86th annual congress of the Swiss Society of Pathology (2020) (0)
- EGFR Exon-Level Biomarkers Of The Response To Bevacizumab-Erlotinib (BE) In Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) - A Translational Substudy Of SAKK 19/05 (2012) (0)
- The Lungscape Project. (2012) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Lukas Bubendorf?
Lukas Bubendorf is affiliated with the following schools:
